Literature DB >> 3098151

High-dose busulfan and myoclonic epilepsy.

R W Martell, C Sher, P Jacobs, F Monteagudo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3098151     DOI： 10.7326/0003-4819-106-1-173_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  The effect of hepatic enzyme inducers on busulfan neurotoxicity and myelotoxicity.

Authors:  W E Fitzsimmons; R Ghalie; H Kaizer
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

Review 3.  The role of busulfan in bone marrow transplantation.

Authors:  M Hassan
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

4.  In vivo distribution of [11C]-busulfan in cynomolgus monkey and in the brain of a human patient.

Authors:  M Hassan; G Oberg; K Ericson; H Ehrsson; L Eriksson; M Ingvar; S Stone-Elander; J O Thorell; B Smedmyr; N Warne
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.

Authors:  M Hassan; G Oberg; M Björkholm; I Wallin; M Lindgren
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 6.  Busulfan in hematopoietic stem cell transplantation.

Authors:  Stefan O Ciurea; Borje S Andersson
Journal:  Biol Blood Marrow Transplant       Date:  2009-02-12       Impact factor: 5.742
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.